• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/23

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

23 Cards in this Set

  • Front
  • Back

Pharmacotherapeutics of SMZ-TMP include all of the following except




a. Pneumocystis carinii pneumonia.


b. Legionnaire’s disease.


c. histoplasmosis.


d. urinary tract infections.

c

Sulfonamides work by




a. inhibiting protein synthesis.


b. interfering with folic acid synthesis.


c. disrupting cell wall matrix.


d. inhibiting replication of DNA.

b

During therapy with SMZ-TMP, the patient should be advised to




a. avoid sunlight.


b. avoid cranberry juice or foods that acidify urine.


c. increase uid intake.


d. All of the above.

d

A potential adverse effect associated with the administration of SMZ-TMP is




a. crystalluria.


b. chronic heart failure.


c. iron deciency anemia.


d. migraine headache.

a

A potential adverse effect to the infant who receives SMZ-TMP from breast-feeding is




a. kernicterus.


b. hepatitis.


c. pancreatitis.


d. aplastic anemia.

a

A benet of fosfomycin (Monurol) therapy is




a. one-time-a-day dosing.


b. 3-day duration of therapy.


c. one-time-only dosing.


d. one-time-a-week dosing.

c

Which of the following statements concern-ing urinary tract antiseptics is accurate?




a. They reach low systemic levels


b. They have many adverse effects because of their toxicity


c. They have many drug–drug interactions


d. They are the drug of choice for acute UTI

a

Nitrofurantoin (Macrodantin) is associated with adverse effects in the




a. CNS.


b. cardiovascular system.


c. pulmonary system.


d. urinary system.

c

Treatment with which of the following drugs will result in bright orange-red urine?




a. Phenazopyridine (Pyridium)


b. Sulsoxazole (Novosoxazole)


c. Nitrofurantoin (Macrodantin)


d. Spectinomycin

a

Although phenazopyridine (Pyridium) is frequently used in the management of UTI, it




a. has more adverse effects than benets.


b. has no antibacterial activity.


c. is more frequently used in the manage-ment of viral illness.


d. is not FDA approved.

b

Your 66-year-old patient is a homeless alco-holic who comes to the clinic with a report of dysuria and hematuria. The patient receives a diagnosis of pyelonephritis and is prescribed a course of SMZ-TMP. Because of this patient’s health status history, which of the following lab tests would be appropriate before initiating therapy?




a. Renal function and arterial blood gas


b. Folate level and complete blood count (CBC)


c. Hepatic enzymes and folate level


d. Arterial blood gas and hepatic enzymes

c

To maximize the effects of SMZ-TMP, a patient should be advised to take the medication




a. on an empty stomach.


b. with a glass of cranberry juice.


c. with a high-fat meal.


d. at bedtime.

a

Your patient is taking SMZ-TMP for PCP prophylaxis. What instructions should be given to this patient?




a. Limit your intake of water.


b. Drink at least four glasses of cranberry juice per day.


c. Increase your uids to at least 1 liter per day.


d. Increase your intake of dairy products.

c

Patients receiving long-term therapy with SMZ-TMP should have periodic laboratory testing, including




a. uric acid levels and liver function.


b. pulmonary function tests and CBC.


c. ophthalmic exams and renal function tests.


d. CBC, liver function, and renal function tests.

d

Your patient is taking SMZ-TMP for PCP pro-phylaxis. Jeffrey comes to the clinic today with a report of fatigue, sore throat, and easy bruis-ing. What do you suspect may be the problem?





a. Viral pharyngitis


b. Anemia


c. Strep throat


d. Mononucleosis

b

Your patient has been prescribed fosfomycin (Monurol) for an acute UTI. Patient education should include instructions to





a. drink the medication immediately after dissolving the powder.


b. crush the capsules and mix in applesauce.


c. inhale from the metered-dose inhaler as needed.


d. let the dissolved powder sit for 1 hour before consuming.

a

Your 81-year-old patient has a urinary tract infection. This patient has an indwelling catheter. Which of the following medications would be inappropriate for the treatment of this patient’s UTI?




a. Sulfamethoxazole-trimethoprim (SMZ-TMP)


b. Sulsoxazole (Novosoxazole)


c. Methenamine (Hiprex)


d. Nitrofurantoin (Furadantin)

c

Your patient has pyelonephritis. The patient reports a constant burning sensation in the lower abdomen and frank pain with voiding. Which of the following drugs would be help-ful in alleviating the discomfort this patient is experiencing?





a. Phenazopyridine (Pyridium)


b. Nitrofurantoin (Macrodantin)


c. Methenamine (Hiprex)


d. Sulfasalazine (Azuldine)

a

Your patient is being given a prescription for SMZ-TMP to treat a urinary tract infection. Teaching should emphasize which of the fol-lowing?




a. Take the drug with food if GI upset occurs.


b. Drink at least 1,500 mL per day.


c. Use sunscreen and protective clothing outside.


d. All of the above e. None of the above

d

Your patient is 70 years old, uroseptic, and begins a regimen of IV SMZ-TMP. To minimize the risk of adverse effects, you should closely monitor the patient’s




a. CBC.


b. fasting blood glucose/sugar (FBG or FBS).


c. daily weight.


d. distance vision.

a

You are following up on a patient with AIDS who has received SMZ-TMP therapy for several months to prevent Pneumocystis jiroveci pneu-monia infections. As part of ongoing assessment and evaluation of therapy when the patient returns for follow-up appointments, you should




a. determine the intake and output levels.


b. assess for urine pH below 5.5.


c. assess urine for crystals.


d. All of the above.


e. None of the above.

d

You are to administer SMZ-TMP via IV infusion to a patient with a severe urinary tract infection. To minimize adverse effects, you should




a. administer as an IV bolus.


b. refrigerate diluted solutions before administration.


c. avoid ushing IV lines used to administer SMZ-TMP.


d. All of the above


e. None of the above

e

Which of these statements, if made by a patient who has been prescribed SMZ-TMP, would indicate a need for further teaching?




a. “I will limit my sun exposure.”


b. “ I will not breast-feed my daughter while I am taking this drug.”


c. “ I will limit drinking alcohol to just on the weekends when someone else can drive me home.”


d. “I will increase the amount of water I drink.”

c